Transmissibility of MERS-CoV infection in closed setting, Riyadh, Saudi Arabia, 2015

Emerging Infectious Diseases

Volumn 25, Issue 10, 2019, Pages 1802-1809

  van Kerkhove, Maria D ^b   Aswad, Sadoof ^b   Assiri, Abdullah ^b   Perera, Ranawaka A P M ^b   Peiris, Malik ^b   El Bushra, Hassan E ^b   BinSaeed, Abdulaziz A ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; ASTHMA; BREAST CANCER; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROEPIDEMIOLOGY; VIRUS VIRULENCE; AIR CONDITIONING; CORONAVIRUS INFECTION; EPIDEMIC; EPIDEMIOLOGY; HOUSING; PATHOGENICITY; SAUDI ARABIA; UNIVERSITY; VIROLOGY;

ADULT; AIR CONDITIONING; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; FEMALE; HOUSING; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RISK FACTORS; SAUDI ARABIA; UNIVERSITIES;

EID: 85072366595     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2510.190130     Document Type: Article

References (38)

1. Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis. 2013;19:1819–23. https://doi.org/10.3201/eid1911.131172
2. World Health Organization. Middle East respiratory syndrome–coronavirus– update: 29 May 2013 [cited 2013 May 30]. http://www.who.int/csr/don/2013_05_29_ncov
3. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–20. https://doi.org/10.1056/NEJMoa1211721
4. Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N, et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013;19(Suppl 1):S12–8. https://doi.org/10.26719/2013.19.supp1.S12
5. FAO-OIE-WHO MERS Technical Working Group. MERS: progress on the global response, remaining challenges and the way forward. Antiviral Research. 2018;159:35–44.
6. Ben Embarek PK, Van Kerkhove MD. Middle East respiratory syndrome coronavirus (MERS-CoV): current situation 3 years after the virus was first identified. Wkly Epidemiol Rec. 2015; 90:245–50.
7. Drosten C, Muth D, Corman VM, Hussain R, Al Masri M, HajOmar W, et al. An observational, laboratory-based study of outbreaks of Middle East respiratory syndrome coronavirus in Jeddah and Riyadh, Kingdom of Saudi Arabia, 2014. Clin Infect Dis. 2015;60:369–77. https://doi.org/10.1093/cid/ciu812
8. Ki M. 2015 MERS outbreak in Korea: hospital-to-hospital transmission. Epidemiol Health. 2015;37:e2015033.
9. Drosten C, Meyer B, Müller MA, Corman VM, Al-Masri M, Hossain R, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014;371:828–35. https://doi.org/10.1056/ NEMoa1405858
10. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) [cited 2019 Jul 30]http://www.who.int/ emergencies/mers-cov
11. Al Hosani F, Pringle K, Al Mulla M, Kim L, Pham H, Alami NN, et al. Response to emergence of Middle East respiratory syndrome coronavirus, Abu Dhabi, United Arab Emirates, 2013–2014. Emerg Infect Dis. 2016;22:1162–8. https://dx.doi.org/10.3201/eid2207.160040
12. Alraddadi B, Bawareth N, Omar H, Alsalmi H, Alshukairi A, Qushmaq I, et al. Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital. Ann Thorac Med. 2016;11:128–31. https://doi.org/10.4103/1817-1737.180027
13. World Health Organization. Disease outbreak news [cited 2019 Jul 30]. http://www.who.int/csr/don/22-june-2016-mers-saudi-arabia
14. Memish ZA, Zumla AI, Assiri A. Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med. 2013;369:884–6. https://doi.org/10.1056/NEJMc1308698
15. Oboho IK, Tomczyk SM, Al-Asmari AM, Banjar AA, Al-Mugti H, Aloraini MS, et al. 2014 MERS-CoV outbreak in Jeddah—a link to health care facilities. N Engl J Med. 2015;372:846–54. https://doi.org/10.1056/NEJMoa1408636
16. Moon SY, Son JS. Infectivity of an asymptomatic patient with Middle East respiratory syndrome coronavirus infection. Clin Infect Dis. 2017;64:1457–8.
17. Kingdom of Saudi Arabia Ministry of Health. Weekly monitor MERS-CoV. 3 November 2015 [cited 2019 Jul 24]. https://www.moh.gov.sa/en/CCC/Documents/Volume-2-Issue11-Tuesday-March-15-2016.pdf
18. World Health Organization. Seroepidemiological investigation of contacts of Middle East respiratory syndrome coronavirus (MERS-CoV) patients [cited 2019 Aug 1]. https://www.who.int/csr/disease/coronavirus_infections/who-close-non-hcw-contact-protocol-merscov.docx?ua=1
19. Command and Control Center SAB. Kingdom of Saudi Arabia Ministry of Health. Middle East respiratory syndrome coronavirus guidelines for healthcare professionals [cited 2019 Aug 1]. https://www.moh.gov.sa/CCC/healthp/regulations/Documents/ MERS-CoV%20Guidelines%20for%20Healthcare%20Professionals%20-%20May%202018%20-%20v5.1%20%281%29.pdf
20. World Health Organization. Guidance on regulations for the transport of infectious substances 2015–2016 [cited 2019 Jun 5]. http://www.who.int/ihr/publications/who_hse_ihr_2015.2
21. Choe PG, Perera RAPM, Park WB, Song K-H, Bang JH, Kim ES, et al. MERS-CoV antibody responses 1 year after symptom onset, South Korea, 2015. Emerg Infect Dis. 2017;23:1079–84. https://dx.doi.org/10.3201/eid2307.170310
22. Al-Abdely HM, Midgley CM, Alkhamis AM, Abedi GR, Tamin A, Binder AM, et al. Infectious MERS-CoV isolated from a mildly ill patient, Saudi Arabia. Open Forum Infect Dis. 2018;5:ofy111. https://doi.org/10.1093/ofid/ofy111
23. Arwady MA, Alraddadi B, Basler C, Azhar EI, Abuelzein E, Sindy AI, et al. Middle East respiratory syndrome coronavirus transmission in extended family, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22:1395–402. https://doi.org/10.3201/eid2208.152015
24. Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk.Lancet. 2013;382:694–9. https://doi.org/10.1016/ S0140-6736(13)61492-0
25. Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014;14:50–6.
26. Hui DS, Azhar EI, Kim Y-J, Memish ZA, Oh M-d, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18:e217-e27.
27. World Health Organization. WHO MERS global summary and assessment of risk: August 2018 [cited 2019 Jun 5]. https://www.who.int/csr/disease/coronavirus_infections/risk-assessment-august-2018.pdf
28. World Health Organization. Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection [cited 2019 Jun 5]. https://www.who.int/csr/disease/coronavirus_infections/ipc-mers-cov
29. BinSaeed AA, Abedi GR, Alzahrani AG, Salameh I, Abdirizak F, Alhakeem R, et al. Surveillance and testing for Middle East respiratory syndrome coronavirus, Saudi Arabia, April 2015–February 2016. Emerg Infect Dis. 2017;23:682–5. https://doi.org/10.3201/eid2304.161793
30. Van Kerkhove MD, Peiris MJS, Malik MR, Ben Embarek P. Interpreting results from environmental contamination studies of Middle East respiratory syndrome coronavirus. Clin Infect Dis. 2016;63:1142. https://doi.org/10.1093/cid/ciw478
31. Kim S-H, Chang SY, Sung M, Park JH, Bin Kim H, Lee H, et al. Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS outbreak units. Clin Infect Dis. 2016;63:363–9.
32. Bin SY, Heo JY, Song M-S, Lee J, Kim E-H, Park S-J, et al. Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis. 2016;62:755–60. https://doi.org/10.1093/cid/civ1020
33. van Doremalen N, Bushmaker T, Munster VJ. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill. 2013;18:20590. https://doi.org/10.2807/1560-7917.ES2013.18.38.20590
34. World Health Organization. Assessment of potential risk factors of Middle East respiratory syndrome coronavirus (MERS-CoV) infection among health care personnel in a health care setting [cited 2019 Jan 1]. https://www.who.int/csr/disease/coronavirus_infections/who-generic_healthcare-mers-seroepi-investigation.docx
35. Park SW, Perera RA, Choe PG, Lau EH, Choi SJ, Chun JY, et al. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 2015;20:30042. https://doi.org/10.2807/1560-7917.ES.2015.20.41.30042
36. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18:20574. https://doi.org/10.2807/1560-7917.ES2013.18.36.20574
37. Ko JH, Müller MA, Seok H, Park GE, Lee JY, Cho SY, et al. Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity. Diagn Microbiol Infect Dis. 2017;89:106–11.
38. Vatcheva KP, Lee M, McCormick JB, Rahbar MH. Multicollinearity in regression analyses conducted in epidemiologic studies. Epidemiology (Sunnyvale). 2016;6:227.